Israel has confirmed a rare case of hantavirus infection in a patient believed to have contracted the disease during a stay in Eastern Europe, prompting health authorities to closely monitor the situation amid growing international attention surrounding recent hantavirus outbreaks abroad. Officials said the patient is currently in stable condition and remains under medical observation.
According to local media reports, the individual sought medical treatment after developing symptoms consistent with hantavirus infection. Initial medical testing reportedly revealed antibodies indicating exposure to the virus. Subsequent PCR testing later confirmed the presence of hantavirus genetic material, officially establishing the diagnosis.
Health officials stated that although the patient is being monitored carefully, the infection has not progressed to a critical stage requiring intensive care treatment or strict isolation procedures. Authorities also confirmed that the case has been formally reported to Israel’s Health Ministry, which is now assessing the situation and tracking any possible public health implications.
While hantavirus infections are considered uncommon in Israel, this is not the first time Israeli citizens have reportedly contracted the disease while travelling abroad. Around a decade ago, several Israeli travellers were suspected of becoming infected during visits to parts of South America, where more severe strains of the virus are known to circulate.
In the current case, however, medical experts believe the patient was infected with a European strain of hantavirus rather than the more dangerous Andes strain associated with outbreaks in South America. Health officials noted that different strains of hantavirus can produce varying symptoms and levels of severity depending on the region and virus type involved.
The Andes strain has recently drawn significant international concern following an outbreak linked to the expedition cruise ship MV Hondius. At least three passengers connected to the vessel have died while several others developed serious respiratory symptoms during the voyage.
The MV Hondius had departed from Ushuaia in Argentina and travelled through Antarctica and remote South Atlantic islands before eventually anchoring off Cape Verde. The vessel was carrying approximately 147 passengers and crew members from 23 countries during the expedition. Several infected passengers have since been evacuated for treatment, while health authorities continue monitoring the remaining passengers and crew.
The outbreak aboard the cruise ship has prompted increased monitoring efforts by international health agencies, including the World Health Organization and the Centers for Disease Control and Prevention. Authorities are currently tracing passengers who may have been exposed to the virus during the voyage and monitoring for any additional cases that may emerge because hantavirus can incubate for several weeks before symptoms appear.
Despite growing attention surrounding recent cases, health experts continue to emphasise that the overall risk to the general public remains low. Officials have repeatedly clarified that most strains of hantavirus do not spread easily between humans and that widespread community transmission is not expected.
Hantavirus is primarily transmitted through contact with infected rodents or by inhaling airborne particles contaminated by rodent urine, saliva or droppings. Individuals may become infected after exposure to contaminated environments such as poorly ventilated spaces, storage areas or rural locations where infected rodents are present.
The illness often begins with symptoms resembling a common viral infection, including fever, headaches, muscle pain and fatigue. Depending on the strain involved, the disease can later progress into severe respiratory complications or kidney-related illness. Some forms of hantavirus infection, particularly those associated with the Americas, can become life-threatening if not identified and treated early.
Medical experts note that there is currently no specific antiviral cure or vaccine widely available for hantavirus infections. As a result, prevention, early diagnosis and supportive medical care remain the primary methods of managing the disease and reducing severe outcomes.
Israeli health authorities are expected to continue monitoring the patient’s condition while remaining alert to any further developments linked to international hantavirus outbreaks currently under investigation.
